ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,738.17
-0.13%
Dow Jones
42,313.00
0.33%
US Dollar vs MXN
19.70728
0.43%
Brent Oil
71.855
1.28%
Bitcoin
65,734.77
0.85%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Bivictrix Therapeutics Plc (BVX)

  7. Bivictrix Therapeutics Plc (BVX) Noticias

BVX

Bivictrix Therapeutics (BVX)

Bivictrix Therapeutics Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:BVX
FechaHoraFuenteTítuloSímboloCompañía
11/09/202401:00RNS Regulatory NewsAIM Cancellation - BiVictriX Therapeutics plcLSE:BVXBivictrix Therapeutics Plc
10/09/202405:04RNS Regulatory NewsBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
10/09/202401:00RNS Regulatory NewsBiVictriX Therapeutics PLC Last Day of DealingsLSE:BVXBivictrix Therapeutics Plc
09/09/202409:35Alliance NewsAlliance NewsBivictrix Therapeutics optimistic about BVX002 after in vivo testingLSE:BVXBivictrix Therapeutics Plc
09/09/202401:00RNS Regulatory NewsBiVictriX Therapeutics PLC Positive In Vivo Data from BVX002 ProgrammeLSE:BVXBivictrix Therapeutics Plc
02/09/202402:50RNS Regulatory NewsBiVictriX Therapeutics PLC Director DealingLSE:BVXBivictrix Therapeutics Plc
29/08/202411:05RNS Regulatory NewsBiVictriX Therapeutics PLC Result of General MeetingLSE:BVXBivictrix Therapeutics Plc
19/08/202401:00RNS Regulatory NewsBiVictriX Therapeutics PLC TR-1: Notification of major holdingsLSE:BVXBivictrix Therapeutics Plc
13/08/202401:00RNS Regulatory NewsBiVictriX Therapeutics PLC Grant of OptionsLSE:BVXBivictrix Therapeutics Plc
12/08/202404:58Alliance NewsAlliance NewsBivictrix Therapeutics to delist as AIM offers insufficient liquidityLSE:BVXBivictrix Therapeutics Plc
12/08/202401:00RNS Regulatory NewsBiVictriX Therapeutics PLC Proposed Voluntary DelistingLSE:BVXBivictrix Therapeutics Plc
01/08/202401:00RNS Regulatory NewsBiVictriX Therapeutics PLC Interim ResultsLSE:BVXBivictrix Therapeutics Plc
24/07/202411:00RNS Regulatory NewsBiVictriX Therapeutics PLC Result of Annual General MeetingLSE:BVXBivictrix Therapeutics Plc
26/06/202401:00RNS Regulatory NewsBiVictriX Therapeutics PLC Publication of 2023 Annual Report & Notice of AGMLSE:BVXBivictrix Therapeutics Plc
13/06/202413:40Alliance NewsAlliance NewsEARNINGS AND TRADING: Dialight trades in line; Petards swings to lossLSE:BVXBivictrix Therapeutics Plc
13/06/202401:00RNS Regulatory NewsBiVictriX Therapeutics PLC Compelling Safety Profile of BVX001LSE:BVXBivictrix Therapeutics Plc
06/06/202401:00RNS Regulatory NewsBiVictriX Therapeutics PLC Innovate UK Grant Award to Accelerate ADC PipelineLSE:BVXBivictrix Therapeutics Plc
31/05/202413:00Alliance NewsAlliance NewsEARNINGS AND TRADING: CT UK High Income tops benchmark, ups dividendLSE:BVXBivictrix Therapeutics Plc
31/05/202402:44RNS Regulatory NewsBiVictriX Therapeutics PLC BiVictriX – Full Year Results 2023LSE:BVXBivictrix Therapeutics Plc
17/04/202408:23Alliance NewsAlliance NewsBivictrix granted FDA orphan drug status for rare cancer treatmentLSE:BVXBivictrix Therapeutics Plc
17/04/202401:00RNS Regulatory NewsBiVictriX Therapeutics PLC Orphan Drug Designation & FDA INTERACT MeetingLSE:BVXBivictrix Therapeutics Plc
28/03/202402:00RNS Regulatory NewsBiVictriX Therapeutics PLC Grant of Options – PDMR/Director DealingsLSE:BVXBivictrix Therapeutics Plc
04/01/202401:00UK RegulatoryBiVictriX Therapeutics PLC BiVictriX Hosts Inaugural Roundtable DiscussionLSE:BVXBivictrix Therapeutics Plc
05/12/202305:08UK RegulatoryBiVictriX Therapeutics PLC Board ChangeLSE:BVXBivictrix Therapeutics Plc
30/11/202306:08Alliance NewsAlliance NewsIN BRIEF: Bivictrix selects final sequences for lead tumour programmeLSE:BVXBivictrix Therapeutics Plc
30/11/202301:00UK RegulatoryBiVictriX Therapeutics PLC Pipeline update on BVX002LSE:BVXBivictrix Therapeutics Plc
15/11/202307:05Alliance NewsAlliance NewsTRADING UPDATES: BiVictriX patent boost; 4Global deal extendedLSE:BVXBivictrix Therapeutics Plc
15/11/202301:00UK RegulatoryBiVictriX Therapeutics PLC Patent Granted in JapanLSE:BVXBivictrix Therapeutics Plc
12/10/202306:04Alliance NewsAlliance NewsBivictrix says BVX001 increases survival rates by more than doubleLSE:BVXBivictrix Therapeutics Plc
12/10/202301:00UK RegulatoryBiVictriX Therapeutics PLC Extended Survival Rates Reported with BVX001LSE:BVXBivictrix Therapeutics Plc
 Showing the most relevant articles for your search:LSE:BVX

Su Consulta Reciente

NASDAQ
CCFI
LSE
FJ00
Citi Fun 24
LSE
PZ94
Citi Fun 28
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados